Your browser doesn't support javascript.
loading
An assessment of shedding with the oral rabies virus vaccine strain SPBN GASGAS in target and non-target species.
Vos, Ad; Freuling, Conrad; Ortmann, Steffen; Kretzschmar, Antje; Mayer, Dietmar; Schliephake, Annette; Müller, Thomas.
Afiliação
  • Vos A; IDT Biologika GmbH, Am Pharmapark, 06861 Dessau-Rosslau, Germany. Electronic address: ad.vos@idt-biologika.de.
  • Freuling C; Friedrich Loeffler Institute, Südufer 10, 17493 Greifswald-Insel Riems, Germany.
  • Ortmann S; IDT Biologika GmbH, Am Pharmapark, 06861 Dessau-Rosslau, Germany.
  • Kretzschmar A; IDT Biologika GmbH, Am Pharmapark, 06861 Dessau-Rosslau, Germany.
  • Mayer D; IDT Biologika GmbH, Am Pharmapark, 06861 Dessau-Rosslau, Germany.
  • Schliephake A; Federal State Agency Saxony-Anhalt for Consumer Protection, Haferbreiter Weg 132-135, 39576 Stendal, Germany.
  • Müller T; Federal State Agency Saxony-Anhalt for Consumer Protection, Haferbreiter Weg 132-135, 39576 Stendal, Germany.
Vaccine ; 36(6): 811-817, 2018 02 01.
Article em En | MEDLINE | ID: mdl-29325820
ABSTRACT
A safety requirement for live vaccines is investigating possible shedding in recipients since the presence of replication competent vaccine in secretions could result in direct and indirect horizontal transmission. This is especially relevant for oral rabies vaccine baits that are deliberately distributed into the environment. In the current study, survival of an oral rabies virus vaccine, SPBN GASGAS, was examined in excretions from different target and non-target species; red fox, raccoon dog, small Indian mongoose, raccoon, striped skunk, domestic dog, domestic cat and domestic pig. Saliva - and (pooled) fecal samples collected at different time points after oral administration of the vaccine strain were examined for the presence of viral RNA (rt-PCR). All PCR-positive and a subset of PCR-negative samples were subsequently investigated for the presence of infectious virus by isolation in cell culture (RTCIT). Up to 7 days post vaccine administration viral RNA could be detected in 50 of 758 fecal samples but no infectious virus was detected in any of the examined PCR-positive fecal samples. In contrast, RNA-fragments were detected in 248 of 1053 saliva swabs for an extended period (up to 10 days) after vaccine administration, but viable virus was only present during the first hours post vaccine administration in 38 samples. No infectious vaccine virus was isolated in saliva swabs taken 24 h or more after vaccine administration. Hence, no active shedding of the vaccine virus SPBN GASGAS after oral administration occurred and the virus isolated during the initial hours was material originally administered and not a result of virus replication within the host. Thus, potential horizontal transmission of this vaccine virus is limited to a short period directly after vaccine bait uptake. It can be concluded that the environmental risks associated with shedding after distributing vaccine baits containing SPBN GASGAS are negligible.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Raiva / Vírus da Raiva / Vacina Antirrábica / Eliminação de Partículas Virais Limite: Animals Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Raiva / Vírus da Raiva / Vacina Antirrábica / Eliminação de Partículas Virais Limite: Animals Idioma: En Ano de publicação: 2018 Tipo de documento: Article